HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Stevanin Selected Research

Hereditary Spastic Paraplegia

1/2022CNS-associated T-lymphocytes in a mouse model of Hereditary Spastic Paraplegia type 11 (SPG11) are therapeutic targets for established immunomodulators.
1/2020Lipids in the Physiopathology of Hereditary Spastic Paraplegias.
1/2019Hereditary spastic paraplegias: time for an objective case definition and a new nosology for neurogenetic disorders to facilitate biomarker/therapeutic studies.
1/2018Inhibition of Lysosome Membrane Recycling Causes Accumulation of Gangliosides that Contribute to Neurodegeneration.
1/2017Mitochondrial morphology and cellular distribution are altered in SPG31 patients and are linked to DRP1 hyperphosphorylation.
8/2015Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
5/2015Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia.
2/2015Fe/S protein assembly gene IBA57 mutation causes hereditary spastic paraplegia.
7/2013Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.
2/2013Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Stevanin Research Topics

Disease

20Spinocerebellar Ataxias (Spinocerebellar Ataxia)
06/2017 - 01/2002
17Hereditary Spastic Paraplegia
01/2022 - 04/2007
11Cerebellar Ataxia (Dysmetria)
01/2022 - 07/2002
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018 - 02/2006
7Ataxia (Dyssynergia)
01/2022 - 02/2006
7Paraplegia (Spastic Paraplegia)
12/2018 - 03/2011
4Atrophy
01/2013 - 07/2003
3Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 05/2008
3Huntington Disease (Huntington's Disease)
06/2016 - 07/2003
2Cognitive Dysfunction
01/2020 - 09/2015
2Inborn Genetic Diseases (Disease, Hereditary)
10/2018 - 03/2006
2Optic Atrophy
12/2017 - 02/2015
2Cardiomyopathies (Cardiomyopathy)
12/2017 - 11/2014
2Channelopathies
06/2017 - 11/2015
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2016 - 09/2014
2Parkinsonian Disorders (Parkinsonism)
09/2015 - 01/2009
2Peripheral Nervous System Diseases (PNS Diseases)
02/2015 - 10/2011
2Tremor (Tremors)
10/2011 - 01/2009
1Disease Progression
01/2022
1Neuroinflammatory Diseases
01/2022
1Medulloblastoma
01/2021
1Hyperargininemia
01/2020
1Quadriplegia (Spastic Quadriplegia)
01/2020
1Leukoencephalopathies
10/2018
1Deafness (Deaf Mutism)
02/2018
1recessive Spastic paraplegia type 5A
01/2018
1Inborn Errors Metabolism (Inborn Errors of Metabolism)
12/2017
1Nervous System Diseases (Neurological Disorders)
01/2017
1Cytochrome-c Oxidase Deficiency
01/2017
1Nervous System Heredodegenerative Disorders
06/2016
1Parkinson Disease (Parkinson's Disease)
02/2016
1Spastic ataxia Charlevoix-Saguenay type
12/2015
1Huntington Disease-Like 2
10/2015
1Frontotemporal Dementia (Semantic Dementia)
09/2014
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
09/2014
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
09/2014
1Neurodegeneration with brain iron accumulation (NBIA)
07/2014
1autosomal recessive Spastic paraplegia 26
07/2013
1Multiple Sclerosis
06/2013
1Karak Syndrome
01/2013
1Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile)
01/2013
1Spastic Paraparesis
10/2012
1Optic Nerve Diseases (Optic Neuropathy)
10/2012
1Adducted Thumbs) Syndrome Shuffling Gait Aphasia MASA (Mental Retardation
07/2012
1Dementia (Dementias)
10/2011

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2005
12polyglutamineIBA
06/2017 - 01/2002
5Biomarkers (Surrogate Marker)IBA
01/2019 - 10/2012
5Ataxin-7IBA
11/2014 - 06/2002
4tributyl phosphate (TBP)IBA
06/2017 - 07/2003
3Biological ProductsIBA
01/2022 - 09/2014
3SpastinIBA
12/2018 - 04/2007
3Nonsense Codon (Nonsense Mutation)IBA
02/2016 - 11/2014
3protein kinase C gamma (PRKCG)IBA
06/2007 - 08/2004
2LipidsIBA
01/2021 - 01/2020
2GangliosidesIBA
01/2018 - 07/2013
2CholesterolIBA
01/2018 - 05/2008
2CalciumIBA
11/2015 - 12/2010
2DNA (Deoxyribonucleic Acid)IBA
05/2015 - 08/2012
2NucleotidesIBA
02/2015 - 11/2010
2IronIBA
07/2014 - 01/2013
2TATA-Box Binding Protein (TATA-Binding Protein)IBA
01/2008 - 07/2003
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2022
1Mitochondrial RNAIBA
01/2022
1PolymersIBA
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1teriflunomideIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1ArginaseIBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
01/2020
1Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate ElevationIBA
10/2018
1Lactic Acid (Lactate)FDA LinkGeneric
10/2018
1cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)- somatostatin (CHP1)IBA
02/2018
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2018
1Bile Acids and Salts (Bile Acids)IBA
01/2018
1OxysterolsIBA
01/2018
1Phospholipids (Phosphatides)FDA LinkGeneric
12/2017
1Mitochondrial DNA (mtDNA)IBA
01/2017
1UbiquitinIBA
01/2016
1Cystatin CIBA
01/2016
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
11/2015
1junctophilinIBA
10/2015
1Amino AcidsFDA Link
08/2015
1OrnithineIBA
08/2015
1Opioid Peptides (Opioid Peptide)IBA
07/2013
1preproenkephalinIBA
07/2013
1Dynorphins (Dynorphin)IBA
07/2013
1AtaxinsIBA
06/2013
1Nuclear Proteins (Protein, Nuclear)IBA
06/2013
1Interferon-betaIBA
06/2013
1CytokinesIBA
06/2013
1Glucosylceramidase (Glucocerebrosidase)IBA
02/2013
1Fatty Acids (Saturated Fatty Acids)IBA
12/2012
1EnzymesIBA
12/2012
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
07/2012
1SilverIBA
10/2011
1Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA
05/2011

Therapy/Procedure

1Therapeutics
01/2021
1Ligation
10/2012
1Slit Lamp
03/2011